Internal restructuring
Hessen; Darmstadt; Darmstadt
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

200 - 550 jobs
Number of planned job losses
Job loss
Announcement Date
27 March 2023
Employment effect (start)
27 March 2023
Foreseen end date
31 December 2024


Merck, a German multinational manufacturer of pharmaceutical and chemical products, has announced plans to cut 200 jobs at its headquarters in Darmstadt.

The company cited increased cost pressures from inflation and a slowdown in the semiconductor market as reasons for the job cuts. Therefore, costs in central functions are to be reduced. The 200 jobs affected are from the research and development areas of the pharmaceutical division. No concrete date is given by when the job cuts are to be completed.

The company emphasises that socially acceptable and sustainable solutions are to be found and that redundancies in Darmstadt are excluded until the end of 2025. Another 550 jobs in the purchasing and legal departments in Darmstadt could be affected by the job cuts by the end of 2024, according to the company spokesperson.

During 2022, a business expansion of 370 jobs in Ireland was recorded in the ERM database for Merck (Merck-2022-IE).



Eurofound (2023), Merck, Internal restructuring in Germany, factsheet number 108807, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/108807.